Ethan Wantman's research while affiliated with New York Institute of Technology and other places

... However, few studies with a limited number of patients show an increase in glucose intolerance and hypertension in ART-generated offspring [173][174][175][176]. These data together with the slight increase in obstetrical and perinatal complications, as well as congenital defects observed in ART-generated offspring [176][177][178][179][180], warrant caution. It is of paramount importance to continue followup of the health of IVF-conceived offspring to clarify possible adverse outcomes not only at the delivery but also later in life, during childhood or adulthood. ...

... The most established method of fertility preservation, embryo cryopreservation, costs approximately $12,000 per cycle and is not routinely covered by health insurance [5]. It has been documented that women with cancer were less likely to utilize fertility preservation procedures if they were of lower socioeconomic position [6]. The state of Michigan does not have a state mandate requiring insurers to offer coverage for infertility treatments or assisted reproductive technologies. ...

... Propensity scores were generated using a logistic regression model to estimate the predicted probability of receiving r-hFSH:r-hLH or r-hFSH alone, as a function of the variables recorded by D·I·R centres. For this study, the covariates included in the statistical models were chosen by the clinician co-authors, based on variables that have been reported/validated to predict either live birth or cumulative live birth after OS for ART treatment (Leijdekkers et al. 2018, Ratna et al. 2020, McLernon et al. 2022) and on data that were routinely available in the D·I·R database. ...

... As observed, a large percentage of the patients who answered the questionnaire identified themselves as white, showing the racial disparity in access to assisted reproduction treatments [29,30]. According to Butts (2021), black patients begin the search for infertility research 6 to 15 months after white patients do, and they still take a longer time to perform adequate treatment, which negatively reflects on ovarian reserve, leading them to undergo more cycles of treatment with greater costs and lesser successes, characterizing racial inequalities and the absence of equal access to treatments [31]. ...

... Intelligence in the young adolescent age group was measured from school subject's test scores [43][44][45][46]. ART students scored significantly higher than NC students in reading or language (only from native language score) (p = 0.00001), although significant heterogeneity was acknowledged (I 2 = 94%, p = 0.00001) (Fig. 8A). ...

... The Horizon Study is a cohort of assigned female at birth, primarily cisgender females diagnosed with cancer as AYAs [7]. Eligible participants were 18 years of age or older at survey, assigned female at birth, diagnosed with cancer as an AYA (ages 15-39 years) during 2004-2016 with 1 of the 5 most common cancers in this age group among cisgender women: breast, thyroid, melanoma, gynecologic, or lymphoma [8]. ...

... In the US, the SET rate was 74.1% in 2018 (9), and recent data from the Society of Assisted Reproductive Technology suggest that the use of SET has further increased (78.4% of ART in 2020) (31). Indeed, compared with multiple embryo transfers, neonatal outcomes with SET are improved and include a reduction in the incidence of prematurity (32,33). Although we are unable to ascertain the use of SET in the Center for Disease Control and Prevention database, it seems likely it follows the trend described elsewhere. ...

... Likewise, pregnancies resulting from ART have been historically associated with an increased risk of preterm delivery in singleton pregnancies [7,8] and low birth weight [9,10] compared to pregnancies conceived naturally. A large population-based cohort study comparing births between 2004 and 2016 in the United States [11] found that singleton infants born from infertility treatments using autologous oocytes (78,362 cases) had a higher risk of non-chromosomal defects, cardiovascular and musculoskeletal defects, and major defects than naturally conceived children (1,037,757 cases). Moreover, this risk is increased with treatments involving the ICSI technique, and more so with male infertility (18%, 30%, and 42%, respectively). ...

... A largely unexplored potential explanation for the overlap between nonchromosomal birth defects and leukemia, as well as other pediatric cancers, is the role of nongenetic in utero factors and exposures that could lead to both phenotypes (eg, maternal diabetes) or postnatal exposures that children with birth defects are more likely to receive (eg, diagnostic procedures that involve radiation). 21 However, outside of a recent assessment evaluating the impact of in vitro fertilization (IVF) on the co-occurrence of birth defects and pediatric cancer, which reported that IVF-exposed children were more likely to develop both birth defects and cancer compared to naturally conceived children, 45 there have been few attempts to evaluate the role of various exposures on the overlap between these conditions. ...

... The majority of these examined negative outcomes following MAR such as in vitro fertilization, intrauterine insemination, and intracytoplasmic sperm injection, among others. Low live birth rates following MAR were found in Black [6,34,40,46,50,51,61,63,65,69,73,76,77,88,90], Asian [6,40,50,51,61,63,69,73,77], Hispanic [6,34,51,57], and Middle Eastern/North African women [75]. Low intrauterine/clinical pregnancy rates were seen in Black [6,51,65,69,85,88], Asian [6,51,65,69,85,88], Hispanic [6,51,69], and American Indian/Alaska Native [33] women. ...